Online inquiry

IVTScrip™ mRNA-Human Aldehyde Dehydrogenase 1-A1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK21392MR)

This product GTTS-WK21392MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the Aldehyde Dehydrogenase 1-A1 protein. This product can be used in Cancer stem cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_000689.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 216
UniProt ID P00352
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human Aldehyde Dehydrogenase 1-A1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK21392MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK16288MR IVTScrip™ mRNA-Human ALAS2, (Cap 0, Pseudo-UTP, 30 nt-poly(A)) mRNA ALAS2
GTTS-WK19692MR IVTScrip™ mRNA-Human ANKLE1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKLE1
GTTS-WK4572MR IVTScrip™ mRNA-Human CD292, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) mRNA CD292
GTTS-WK7639MR IVTScrip™ mRNA-Human ACP2, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ACP2
GTTS-WK26052MR IVTScrip™ mRNA-Human ATG101, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ATG101
GTTS-WK23936MR IVTScrip™ mRNA-Human ATAD2, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ATAD2
GTTS-WK28465MR IVTScrip™ mRNA-Human ATIC, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ATIC
GTTS-WK14287MR IVTScrip™ mRNA-Human ADAL, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ADAL
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW